Precision BioSciences (NASDAQ:DTIL) reported quarterly losses of $(1.84) per share which missed the analyst consensus estimate of $(1.34) by 37.31 percent. This is a 18.22 percent increase over losses of $(2.25) per share from the same period last year. The company reported quarterly sales of $13.000 thousand which missed the analyst consensus estimate of $5.400 million by 99.76 percent. This is a 97.74 percent decrease over sales of $576.000 thousand the same period last year.